Logo image of HQH

ABRDN HEALTHCARE INVESTORS (HQH) Stock Price, Quote, News and Overview

NYSE:HQH - New York Stock Exchange, Inc. - US87911J1034 - Currency: USD

16.24  +0.14 (+0.87%)

Fundamental Rating

3

Overall HQH gets a fundamental rating of 3 out of 10. We evaluated HQH against 0 industry peers in the Unkown industry. HQH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HQH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HQH had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: HQH reported negative net income in multiple years.
HQH had a negative operating cash flow in each of the past 5 years.
HQH Yearly Net Income VS EBIT VS OCF VS FCFHQH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

Industry RankSector Rank
ROA 6.04%
ROE 6.05%
ROIC N/A
ROA(3y)-0.56%
ROA(5y)0.92%
ROE(3y)-0.58%
ROE(5y)0.89%
ROIC(3y)N/A
ROIC(5y)N/A
HQH Yearly ROA, ROE, ROICHQH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

In the last couple of years the Profit Margin of HQH has declined.
The Operating Margin and Gross Margin are not available for HQH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 547.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.26%
PM growth 5Y-11.72%
GM growth 3YN/A
GM growth 5YN/A
HQH Yearly Profit, Operating, Gross MarginsHQH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K 2K -2K

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HQH has been increased compared to 1 year ago.
Compared to 5 years ago, HQH has more shares outstanding
HQH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HQH Yearly Shares OutstandingHQH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
HQH Yearly Total Debt VS Total AssetsHQH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 452.96 indicates that HQH is not in any danger for bankruptcy at the moment.
HQH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 452.96
ROIC/WACCN/A
WACCN/A
HQH Yearly LT Debt VS Equity VS FCFHQH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

HQH has a Current Ratio of 6.01. This indicates that HQH is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.01 indicates that HQH has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 6.01
HQH Yearly Current Assets VS Current LiabilitesHQH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.86% over the past year.
HQH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.02% yearly.
HQH shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.32%.
HQH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.71% yearly.
EPS 1Y (TTM)128.86%
EPS 3Y-40.83%
EPS 5Y-7.02%
EPS Q2Q%67.63%
Revenue 1Y (TTM)24.32%
Revenue growth 3Y4.84%
Revenue growth 5Y8.71%
Sales Q2Q%7.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HQH Yearly Revenue VS EstimatesHQH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.65, the valuation of HQH can be described as correct.
HQH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.88.
Industry RankSector Rank
PE 13.65
Fwd PE N/A
HQH Price Earnings VS Forward Price EarningsHQH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HQH Per share dataHQH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.81%, HQH is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.45, HQH pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.81%

5.2 History

HQH has paid a dividend for at least 10 years, which is a reliable track record.
HQH has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HQH Yearly Dividends per shareHQH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
HQH Yearly Income VS Free CF VS DividendHQH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

More info and screens

ABRDN HEALTHCARE INVESTORS

NYSE:HQH (4/30/2025, 4:15:00 PM)

16.24

+0.14 (+0.87%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.05%
Inst Owner Change0.11%
Ins Owners0.01%
Ins Owner Change0%
Market Cap874.69M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 14.81%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-21 2025-02-21 (0.57)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.65
Fwd PE N/A
P/S 84.97
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)1.19
EY7.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.19
BVpS17.29
TBVpS17.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.04%
ROE 6.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 547.23%
GM N/A
FCFM N/A
ROA(3y)-0.56%
ROA(5y)0.92%
ROE(3y)-0.58%
ROE(5y)0.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.26%
PM growth 5Y-11.72%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.01
Quick Ratio 6.01
Altman-Z 452.96
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.86%
EPS 3Y-40.83%
EPS 5Y-7.02%
EPS Q2Q%67.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.32%
Revenue growth 3Y4.84%
Revenue growth 5Y8.71%
Sales Q2Q%7.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A